| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,885 |
2,768 |
$142K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
16,015 |
14,066 |
$105K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,222 |
2,207 |
$36K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
11,984 |
5,475 |
$32K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,787 |
1,713 |
$29K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
364 |
352 |
$27K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,831 |
1,820 |
$27K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,552 |
2,421 |
$27K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,694 |
1,678 |
$23K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,515 |
4,303 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,191 |
2,493 |
$6K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
178 |
175 |
$5K |
| 99429 |
|
1,016 |
1,006 |
$5K |
| 99215 |
Prolong outpt/office vis |
88 |
88 |
$3K |
| 87634 |
|
46 |
44 |
$2K |
| 99381 |
|
191 |
165 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
82 |
76 |
$1K |
| 87807 |
|
606 |
567 |
$946.00 |
| 90461 |
|
5,388 |
2,681 |
$559.22 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
14 |
14 |
$441.09 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,405 |
1,344 |
$375.36 |
| 90619 |
|
359 |
356 |
$311.18 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
112 |
112 |
$278.44 |
| 83655 |
|
164 |
162 |
$194.36 |
| 92551 |
|
782 |
776 |
$176.76 |
| 85018 |
|
417 |
411 |
$94.19 |
| 97802 |
|
4,190 |
4,154 |
$6.19 |
| 90677 |
|
430 |
430 |
$1.94 |
| 90698 |
|
1,683 |
1,671 |
$0.00 |
| 90651 |
|
783 |
777 |
$0.00 |
| 90688 |
|
893 |
865 |
$0.00 |
| 90680 |
|
1,153 |
1,145 |
$0.00 |
| 90744 |
|
778 |
765 |
$0.00 |
| 90696 |
|
219 |
216 |
$0.00 |
| 90716 |
|
810 |
806 |
$0.00 |
| 36416 |
|
34 |
33 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
128 |
128 |
$0.00 |
| 90656 |
|
66 |
66 |
$0.00 |
| 94761 |
|
13 |
12 |
$0.00 |
| 90707 |
|
802 |
798 |
$0.00 |
| 90670 |
|
1,318 |
1,308 |
$0.00 |
| 99173 |
|
761 |
756 |
$0.00 |
| 90633 |
|
809 |
803 |
$0.00 |
| 90734 |
|
267 |
266 |
$0.00 |
| 90715 |
|
182 |
181 |
$0.00 |
| 90713 |
|
12 |
12 |
$0.00 |
| 81002 |
|
25 |
24 |
$0.00 |
| 90700 |
|
12 |
12 |
$0.00 |